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Placenta increta is a rare condition resulting from
abnormal implantation and invasion of placental tissue
deep into the myometrium. Placenta increta, the second
most common type of abnormal placental implanta-
tion, accounts for 18% of cases, with placenta accreta
being the most common and placenta percreta the
least common (76% and 6% of the cases, respectively).
The incidence of placenta increta has been reported to
be 1:2500 to 1:7000 [1,2]. It has increased during recent
years because of the increased number of cesarean sec-
tions performed. Placenta increta has been associated
with high mortality and morbidity rates because of
severe hemorrhaging, uterine perforation, and infec-
tion. Diagnosis of placenta increta can be made using
ultrasound (US) or magnetic resonance image (MRI),
and the treatment of choice is usually hysterectomy [3].
We present the case of a 30-year-old woman with
placenta increta who was managed initially with uter-
ine artery embolization but underwent hysterectomy
18 weeks later as a result of hemorrhaging.
The patient presented to an outside clinic with de-
layed menses. She was diagnosed with an early intra-
uterine pregnancy at 12 weeks of gestation which was
confirmed using pelvic ultrasonography. Her medical
history was significant for four elective abortions and
three cesarean sections. The patient decided to terminate
the pregnancy and was treated with dilatation and curet-
tage. Postoperatively, she developed massive hemor-
rhaging and was transferred to our hospital for further
management. A hypervascular mass located within the
lower uterine segment (Figure 1) was noted on pelvic
ultrasonography. A 2.7 × 2.3 cm mass within the same
location, suggestive of placenta increta, was noted on
a subsequent MRI (Figure 2). Transarterial uterine artery
embolization (TAE) was performed. Superselective
transarterial embolization of the bilateral uterine arter-
ies and branches, and other vessels as appropriate, was
achieved using a 4F angiocatheter (65 cm, RC1, Super
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Figure 1. Pelvic Doppler ultrasonography revealed a mass
with rich blood flow located at the lower uterine segment.
b = bladder; E = endometrial lining.
Figure 2. Magnetic resonance imaging showed a 2.7 × 2.3 cm
mass within the same location suggestive of placenta increta
(arrow). b = bladder.
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Torque; Cordis, Miami, FL, USA) with pledgets of ab-
sorbable gelatin sponges (Gelfoam; Johnson & Johnson,
Skipton, UK) of varying sizes. Markedly decreased
uteroplacental blood flow was seen immediately in a
postembolization angiographic study. The patient was
discharged in a stable condition 2 days post procedure.
Her serial β-human chorionic gonadotropin (hCG)
and α-fetoprotein levels both decreased to the normal
range at 4 months postoperatively (from 48,121 IU/L
to 0.67 IU/L).
During her follow-up period, the patient continued
to have intermittent vaginal bleeding. She presented to
the emergency department with sudden onset of heavy
vaginal bleeding at 18 weeks after embolization. Her
blood pressure dropped from 126/84 mmHg at pres-
entation to 70/56 mmHg, with a pulse rate of 84/min.
Pelvic US revealed a predominantly nonvascular het-
erogenic mass approximately 3×4 cm located within the
anterior lower uterine segment. Emergency exploratory
laparotomy was performed. Intraoperatively, bleeding
was noted from the mass located within the lower
uterine segment that was bulging into the posterior
wall of the bladder. Difficulty in separating the anterior
wall of the uterus from the bladder was encountered,
because this mass was adhering to the bladder. After
careful dissection, the uterus was separated from the
bladder and total hysterectomy was performed. The
resulting serosal laceration of the bladder was repaired.
The pathology revealed placenta increta (Figure 3). The
postoperative course was uneventful, and the patient
was discharged 3 days after surgery.
As the incidence of cesarean sections has increased,
abnormal placentation has also increased [4]. Placenta
accreta, an abnormal placentation resulting from abnor-
mal implantation, is classified further by the degree of
uterine wall invasion: accreta, increta, and percreta. True
placenta accreta is characterized by invasion of pla-
cental villi through the decidua basalis. Placenta inc-
reta and percreta involve placental invasion into the
myometrium and serosa, respectively.
A two-stage protocol for evaluating women at high
risk of advanced invasive placentation, which uses
two-dimensional US initially, then adjunctive three-
dimensional (3D) US and MRI for cases with suggestive
or inconclusive US features for bladder or surrounding
organ involvement, will optimize diagnostic accuracy.
Outcomes of prenatal 3D US and MRI are equally accu-
rate in defining the area of placental invasion, particularly
those involving the urinary bladder [5]. Furthermore,
MRI may be more useful in evaluating the anatomy 
of topographic regions invaded, such as the ureter or
bowel. However, 3D US is superior to magnetic reso-
nance angiography in evaluating in utero pathologic
neovascularization conditions of invasive placentation
by its potential for dynamic assessment of abnormally
uteroplacental hypervascularity using the power
Doppler mode [6–8].
For many years, hysterectomy was the preferred
treatment for patients with these conditions because
of unacceptably high maternal mortality rates with
conservative management such as leaving all or part of
the placenta in situ, excising the involved myometrium,
and oversewing focal defects. Increasingly, conserva-
tive treatment has been advocated when blood loss is
not excessive, defects are focal, and future fertility is
desired. Low mortality rates have been reported in care-
fully selected patients. Successful conservative manage-
ment of retained placenta accreta, increta and percreta
may result in gradual resorption or delayed delivery of
the placenta.
Conservative adjuvant treatment using methotrex-
ate treatment is controversial [9,10]. Kayem et al [10]
reported that such treatment did not have any proven
benefits. Follow-up measuring hCG, which represents
the activity of the trophoblast, is not a good marker
for persistent placental tissues.
TAE is considered a safe, life-saving procedure in
postpartum hemorrhage and has no major short- or
long-term side effects [11] During recent years, balloon
occlusion has been used in the case of placenta accreta
[5,12]. However, complications from this procedure,
such as iliac artery thrombosis, can be significant [5].
However, conservative treatment had some disad-
vantages, including postpartum infection and even
sepsis, delayed postpartum hemorrhage, treatment fail-
ure, long-term physical and psychologic stress for both
the patients and attending physicians, and restrictive
follow-up. These include all patients who were evaluated
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Figure 3. The pathology of placenta increta. Placental villi
invaded the myometrium without intervening decidua.
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weekly for 6 months using US, clinical examination,
complete blood count, C-reactive protein, and vaginal
samples taken for bacteriologic study in cases of endo-
metritis [13,14]. Nonetheless, although study results
support the use of conservative management to im-
prove the outcome in selected patients, several ques-
tions remain unresolved. These include the optimal
adjuvant management (methotrexate treatment, TAE,
sulprostone uterotonic agent), the long-term progno-
sis, and the risk of rare and grave maternal morbidity
or death [13,14]. On the other hand, failed conserva-
tive management has resulted in infection and acute
hemorrhaging, requiring hysterectomy [15].
In our case, TAE was selected during the first episode
of bleeding. After 18 weeks of close follow-up, despite
a negative hCG and decreased Doppler flow, massive
delayed bleeding developed and hysterectomy was
performed. Conservative treatment of abnormal pla-
centation in selected cases is possible with careful
monitoring.
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